News

for immediate release Toronto, Canada. On December 14th, Cardio-Phoenix Inc. received a 510 (k) clearance for its Cardio-TriTest™ v6.5 medical device from the U.S Food and Drug Administration (FDA). This is the second 510k the company has received, the first being issued June 3rd, 2015. The Cardio-TriTest™ (CTT) device is a non-invasive medical device that collects 3...

Cardio-Phoenix Inc. -  Now ISO 13485:2016 Certified Cardio–Phoenix Inc. is proud to announce that it has received the coveted ISO 13845:2016 certification for the Design and Development of non-invasive diagnostic medical devices. ISO certification of Cardio-Phoenix demonstrates the company’s quality commitment to developing advanced products and novel technology for the early detection of a broad range of...